Regulatory decision in Japan anticipated as early as the end of 2027, subject to PMDA review; GlycoNex continues to seek partners for markets outside Japan NEW TAIPEI CITY, Nov. 8, 2026 /PRNewswire/ -- GlycoNex, Inc. (TPEx: 4168), a clinical-stage biotechnology company developing...